Skip to content

Author

Muhammad Saeed Akhtar

We have 5 of 34 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Catalytic Annulations of Itaconimides: Mechanistic Diversity and Opportunities for More Sustainable Organic Synthesis

Itaconimides combine an electron-deficient terminal methylene group with a succinimide framework, creating a reactive topology that differs from those of maleimides, citraconimides, and substituted α-alkylidene succinimides. This review critically examines annulation reactions of terminal-methylene itaconimides, define...

Mohammad Aslam, Priyanka Raju Thombal, Se-Ho Sun et al. · 0 citations
Review Open access Oct 2026

The Nuclear Damage-Response Code of Cutaneous Wound Repair: Mechanotransduction, cGAS-STING, Senescence, and Regenerative Interfaces

Chronic cutaneous wounds are often described as disorders of inflammation, infection, perfusion, or extracellular matrix turnover, yet these categories do not fully explain why a wound that initially detects injury fails to re-enter a coordinated program of repair. This Perspective proposes a unifying model in which th...

Muhammad Saeed Akhtar, Mohammad Aslam, M. M. Beg · 0 citations
Review Oct 2026

Adaptive Plasma-Membrane Nanodomains in Plants: Integrating Lipids, Receptors, Mechanics and Trafficking During Stress.

The adaptive plasma-membrane nanodomain code is defined as a testable, context-dependent relationship between measured organisational variables - size, density, stoichiometry, diffusion, residence time, lipid dependence and trafficking flux - and specified biochemical or physiological outputs under matched protein abun...

Sajid Ali, Muhammad Saeed Akhtar · 0 citations
Review Sep 2026

Brensocatib in non-cystic fibrosis bronchiectasis: neutrophil serine protease modulation, clinical evidence, and therapeutic positioning.

INTRODUCTION Non-cystic fibrosis bronchiectasis (NCFB) is a chronic airway disease characterized by recurrent infection, mucus retention, neutrophilic inflammation, and pulmonary exacerbations. Brensocatib is an oral, selective, reversible dipeptidyl peptidase 1 (DPP1) inhibitor that reduces neutrophil serine protease...

Muhammad Saeed Akhtar · 0 citations
#gene editing Review Sep 2026

CRISPR–cas systems in pharmacology: functional pharmacogenomics, drug screening, resistance, and therapeutic translation

Overall, CRISPR-Cas9 represents a vital platform for future pharmacological innovation, but its broad clinical use may require further validation of safety, efficacy, durability, and accessibility.

Muhammad Saeed Akhtar, Adnan Amin · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.